2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
#2in1 #covidflu #vaccine #looks #promising
2-in-1 COVID-flu vaccine looks promising in trial — but experts say approval may be delayed
Late-stage trial data suggest that a new COVID-flu vaccine offers good protection against both infections, but experts expect the shot's approval may be delayed.
#2in1 #covidflu #vaccine #looks #promising
·107 Views